Serena Williams' suggestion that injectable weight loss drugs could have helped her in tennis is part of an ongoing ...

According to the notice issued by the Drugs Controller General of India (DCGI), Dr Rajeev Raghuvanshi, "Mis Novo Nordisk has informed about a theft of its products, as mentioned below, during transit ...

Dr Shazia Malik - a consultant obstetrician and gynaecologist for The Portland Hospital - discussed the pros and cons of ...

Discover why Hims & Hers Health's subscriber growth, profitability, and telehealth expansion make it a strong buy with a ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.

Eli Lilly and Company LLY is a key player in the diabetes and obesity drug market, mainly due to the significant popularity ...

In the wake of weight-loss drugs and the rising importance of health, the iconic cultural brand must double down on its roots ...

If you have hypoglycemia during Ozempic treatment, it’s possible that once your blood sugar is stable, the blurred vision will clear. If it doesn’t clear or you have any other vision problems that ...

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...

For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy.